We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$56.6B
AUM Growth
+$2.63B
Cap. Flow
-$307M
Cap. Flow %
-0.54%
Top 10 Hldgs %
29.54%
Holding
969
New
110
Increased
283
Reduced
395
Closed
105

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$292M
2
MMM icon
3M
MMM
+$186M
3
BMY icon
Bristol-Myers Squibb
BMY
+$170M
4
WM icon
Waste Management
WM
+$146M
5
DOV icon
Dover
DOV
+$143M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$199M
2
CSX icon
CSX Corp
CSX
+$197M
3
DE icon
Deere & Co
DE
+$122M
4
COP icon
ConocoPhillips
COP
+$110M
5
RBA icon
RB Global
RBA
+$109M

Sector Composition

Rank Sector Weight
1 Technology 28.49%
2 Healthcare 16.13%
3 Financials 10.57%
4 Consumer Discretionary 9.62%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NE icon
676
Noble Corp
NE
$6.5B
$6.98M 0.01%
193,160
+73,160
+61% +$2.95M
RH icon
677
RH
RH
$3.56B
$6.89M 0.01%
20,600
-20,350
-50% -$5.6M
MRNA icon
678
Moderna
MRNA
$21.5B
$6.88M 0.01%
102,898
-149,555
-59% -$13.7M
BNTX icon
679
BioNTech
BNTX
$22.9B
$6.83M 0.01%
+57,500
New +$5.29M
ARWR icon
680
Arrowhead Research
ARWR
$12.1B
$6.78M 0.01%
350,000
+250,000
+250% +$6.1M
TNDM icon
681
Tandem Diabetes Care
TNDM
$1.29B
$6.77M 0.01%
159,604
+94,604
+146% +$4.01M
ARQ icon
682
Arq
ARQ
$90.6M
$6.75M 0.01%
1,149,518
+909,518
+379% +$5.54M
QRVO icon
683
Qorvo
QRVO
$8.41B
$6.65M 0.01%
64,400
-8,200
-11% -$921K
PRQR icon
684
ProQR Therapeutics
PRQR
$268M
$6.6M 0.01%
3,625,467
VRT icon
685
Vertiv
VRT
$106B
$6.58M 0.01%
+66,157
New +$5.48M
ETNB
686
DELISTED
89bio
ETNB
$6.47M 0.01%
875,000
+475,000
+119% +$3.99M
IVZ icon
687
Invesco
IVZ
$14B
$6.39M 0.01%
364,169
-2,300
-0.6% -$37.8K
EPSN icon
688
Epsilon Energy
EPSN
$170M
$6.22M 0.01%
1,061,909
-50,000
-4% -$267K
FDS icon
689
Factset
FDS
$9.77B
$6.16M 0.01%
13,400
+1,800
+16% +$764K
ABVX
690
Abivax
ABVX
$11.3B
$6.12M 0.01%
530,861
+5,861
+1% +$70.2K
MTB icon
691
M&T Bank
MTB
$36.1B
$6.07M 0.01%
34,090
-15,917
-32% -$2.64M
VERU icon
692
Veru
VERU
$37.1M
$6.05M 0.01%
786,111
PAYC icon
693
Paycom
PAYC
$10.1B
$5.98M 0.01%
35,900
+4,800
+15% +$768K
ORIC icon
694
Oric Pharmaceuticals
ORIC
$1.34B
$5.89M 0.01%
575,000
-205,400
-26% -$2.03M
CCK icon
695
Crown Holdings
CCK
$13.2B
$5.89M 0.01%
61,421
-58,579
-49% -$5.04M
WSC icon
696
WillScot Mobile Mini Holdings
WSC
$4.67B
$5.88M 0.01%
+156,403
New +$5.97M
CYBR
697
DELISTED
CyberArk
CYBR
$5.83M 0.01%
20,000
-35,000
-64% -$9.47M
SLN
698
Silence Therapeutics
SLN
$554M
$5.82M 0.01%
320,000
-280,000
-47% -$5.21M
HBT icon
699
HBT Financial
HBT
$1.32B
$5.8M 0.01%
265,296
-308,354
-54% -$6.75M
GL icon
700
Globe Life
GL
$14.4B
$5.79M 0.01%
54,700
-25,800
-32% -$2.47M

Similar funds

Adage Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Adage Capital Partners held 969 positions worth $56.6B, up 4.9% from $54B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Adage Capital Partners's Q3 2024 filing shows 110 new, 283 increased, 395 reduced and 105 closed positions. Its largest new stake was EQT Corp: 2,636,935 shares worth $96.6M. The largest sale was Merck, an estimated $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2024 buy was EQT Corp: 2,636,935 shares worth $96.6M.
  • Adage Capital Partners added most to Hess in Q3 2024, an estimated $292M increase.
  • Adage Capital Partners's biggest Q3 2024 reduction was Merck, cutting an estimated $199M.
  • Adage Capital Partners fully exited Deere & Co in Q3 2024, selling an estimated $122M.
  • Adage Capital Partners's ten largest holdings make up 30% of its $56.6B portfolio in Q3 2024.
  • Adage Capital Partners opened 110 new positions and closed 105 in Q3 2024.
  • Adage Capital Partners's portfolio value rose 4.9% quarter-over-quarter to $56.6B.

Based on Adage Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.